225 related articles for article (PubMed ID: 20300530)
1. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.
Cestari I; Ramirez MI
PLoS One; 2010 Mar; 5(3):e9721. PubMed ID: 20300530
[TBL] [Abstract][Full Text] [Related]
2. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
[TBL] [Abstract][Full Text] [Related]
3. Differential ability to resist to complement lysis and invade host cells mediated by MBL in R4 and 860 strains of Trypanosoma cruzi.
Evans-Osses I; Mojoli A; Beltrame MH; da Costa DE; DaRocha WD; Velavan TP; de Messias-Reason I; Ramirez MI
FEBS Lett; 2014 Mar; 588(6):956-61. PubMed ID: 24560788
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
Schenkman S; Güther ML; Yoshida N
J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
[TBL] [Abstract][Full Text] [Related]
5. Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.
Arroyo-Olarte RD; Martínez I; Cruz-Rivera M; Mendlovic F; Espinoza B
Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170332. PubMed ID: 29513875
[TBL] [Abstract][Full Text] [Related]
6. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
Norris KA; Bradt B; Cooper NR; So M
J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.
Joiner KA; daSilva WD; Rimoldi MT; Hammer CH; Sher A; Kipnis TL
J Biol Chem; 1988 Aug; 263(23):11327-35. PubMed ID: 3042767
[TBL] [Abstract][Full Text] [Related]
9. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
Rimoldi MT; Sher A; Heiny S; Lituchy A; Hammer CH; Joiner K
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):193-7. PubMed ID: 3277170
[TBL] [Abstract][Full Text] [Related]
10. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
Rimoldi MT; Tartanian A; Joiner KA
Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
[TBL] [Abstract][Full Text] [Related]
11. Host cell invasion and oral infection by Trypanosoma cruzi strains of genetic groups TcI and TcIV from chagasic patients.
Maeda FY; Clemente TM; Macedo S; Cortez C; Yoshida N
Parasit Vectors; 2016 Apr; 9():189. PubMed ID: 27038796
[TBL] [Abstract][Full Text] [Related]
12. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
Norris KA
Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
[TBL] [Abstract][Full Text] [Related]
13. Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process.
Wyllie MP; Ramirez MI
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28859399
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
Yoshida N
Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
[TBL] [Abstract][Full Text] [Related]
15.
Ramírez-Toloza G; Ferreira A
Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
[TBL] [Abstract][Full Text] [Related]
16. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
Joiner K; Sher A; Gaither T; Hammer C
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which Factor H protects
Menon SS; Ramirez-Toloza G; Wycoff KL; Ehinger S; Shaughnessy J; Ram S; Ferreira VP
Front Immunol; 2024; 15():1152000. PubMed ID: 38361922
[TBL] [Abstract][Full Text] [Related]
18. Purification of Trypanosoma cruzi metacyclic trypomastigotes by ion exchange chromatography in sepharose-DEAE, a novel methodology for host-pathogen interaction studies.
Cruz-Saavedra L; Muñoz M; León C; Patarroyo MA; Arevalo G; Pavia P; Vallejo G; Carranza JC; Ramírez JD
J Microbiol Methods; 2017 Nov; 142():27-32. PubMed ID: 28865682
[TBL] [Abstract][Full Text] [Related]
19. Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.
Brunoro GV; Caminha MA; Ferreira AT; Leprevost Fda V; Carvalho PC; Perales J; Valente RH; Menna-Barreto RF
J Proteomics; 2015 Feb; 115():58-65. PubMed ID: 25534883
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
